Loading…
High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6
Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhe...
Saved in:
Published in: | Gut 2002-07, Vol.51 (1), p.120-127 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3 |
---|---|
cites | |
container_end_page | 127 |
container_issue | 1 |
container_start_page | 120 |
container_title | Gut |
container_volume | 51 |
creator | Xu, B Broome, U Ericzon, B-G Sumitran-Holgersson, S |
description | Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients. |
doi_str_mv | 10.1136/gut.51.1.120 |
format | article |
fullrecord | <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_593597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A89076091</galeid><sourcerecordid>A89076091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEoqVw44wsIeDCFjsfdnJBqnaBRargQEGIi-U4k6zbrL3YDm1_Fv-QCRu6LAJkKbFmnvl6PUnykNFjxjL-ohviccGO8aT0VnLIcl7OsrQsbyeHlDIxK0ReHST3QjinlJZlxe4mB4gKwWh-mHxfmm5FWg9fB7D6mriWqCE6ZaOpXWMgEGPJRkUDNgZyaeKKbLxZK39Ngu7Bu2BsR_TK9cp2JppA4kpFUhvb4Kc3IwgbDAO890RD3wei0InAoIHA1cZDCMbZsfR8kec_vRvv0B0ns7ERfA_DBfbC7yd3WtUHeDD9j5KPr1-dzZez0_dv3s5PTmc151WcgW5oXZd1U2c5TlsXaauoyhnLW9rwNK051S1jminNtEjbvGk0ytKUDeNNxuvsKJlt84ZL2Ay1nMaWThk5mS7wBrKosqISyIt_8uM4u6BfgazKMiZyjHy5jUT3GhqNUnvV7yfY81izkp37JpkQWSpKTPB0SuAdvmOIcm3CKLWy4IYgBSszkQuO4OM_wHM3eIsyjrmqKk8FH6nnW6pTPUhjW4dVdQcWsLiz0Bo0n5QVFZxWbCfUHo6ngbXRf-On9Bq3J3hobyZlVI4rLXGlZcEknpQi_uh3dXbwtMMIPJkAFbTqW6-sNmHHZSITHB_ppk8TIlzd-JW_kByRQr77NJeLZXH2efHlgxxleLbl6_X5_1v8Aa1dIXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779942766</pqid></control><display><type>article</type><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><source>PubMed Central</source><creator>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</creator><creatorcontrib>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</creatorcontrib><description>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.51.1.120</identifier><identifier>PMID: 12077104</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>adhesion molecules ; Adult ; Aged ; AIH ; ALDs ; Antigens ; Autoantibodies ; Autoantibodies - blood ; Autoimmune diseases ; autoimmune hepatitis ; autoimmune liver diseases ; BECs ; Bile Ducts - immunology ; biliary epithelial cells ; Binding sites ; Biological and medical sciences ; Case-Control Studies ; Cell Separation ; Cells, Cultured ; Chi-Square Distribution ; Cholangitis ; Cholangitis, Sclerosing - immunology ; Complement Fixation Tests ; cytokines ; Epithelial Cells - immunology ; Female ; FITC ; fluorescein isothiocynate ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatitis ; Hepatitis, Autoimmune - immunology ; Humans ; Hyaluronan Receptors - immunology ; IFN-γ ; Immunoglobulins ; Inflammatory bowel disease ; interferon γ ; interleukin ; Interleukin-6 - biosynthesis ; Interleukin-6 - immunology ; LECs ; Liver and Biliary Disease ; Liver cirrhosis ; Liver Cirrhosis, Biliary - immunology ; Liver diseases ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; lung epithelial cells ; Male ; Measurement ; Medical sciences ; Medicin och hälsovetenskap ; Middle Aged ; Other diseases. Semiology ; Pathogenesis ; Patients ; PBC ; PBS ; phosphate buffered saline ; Physiological aspects ; primary biliary cirrhosis ; primary sclerosing cholangitis ; Protein Binding ; Proteins ; PSC ; Rodents ; SDS-PAGE ; Smooth muscle ; sodium dodecyl sulphate-polyacrylamide gel electrophoresis ; Statistics, Nonparametric ; TNF-α ; tumour necrosis factor α</subject><ispartof>Gut, 2002-07, Vol.51 (1), p.120-127</ispartof><rights>Copyright 2002 by Gut</rights><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2002 Copyright 2002 by Gut</rights><rights>Copyright © Copyright 2002 by Gut 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773278/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773278/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13737659$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12077104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1933174$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, B</creatorcontrib><creatorcontrib>Broome, U</creatorcontrib><creatorcontrib>Ericzon, B-G</creatorcontrib><creatorcontrib>Sumitran-Holgersson, S</creatorcontrib><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><title>Gut</title><addtitle>Gut</addtitle><description>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</description><subject>adhesion molecules</subject><subject>Adult</subject><subject>Aged</subject><subject>AIH</subject><subject>ALDs</subject><subject>Antigens</subject><subject>Autoantibodies</subject><subject>Autoantibodies - blood</subject><subject>Autoimmune diseases</subject><subject>autoimmune hepatitis</subject><subject>autoimmune liver diseases</subject><subject>BECs</subject><subject>Bile Ducts - immunology</subject><subject>biliary epithelial cells</subject><subject>Binding sites</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Cell Separation</subject><subject>Cells, Cultured</subject><subject>Chi-Square Distribution</subject><subject>Cholangitis</subject><subject>Cholangitis, Sclerosing - immunology</subject><subject>Complement Fixation Tests</subject><subject>cytokines</subject><subject>Epithelial Cells - immunology</subject><subject>Female</subject><subject>FITC</subject><subject>fluorescein isothiocynate</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatitis</subject><subject>Hepatitis, Autoimmune - immunology</subject><subject>Humans</subject><subject>Hyaluronan Receptors - immunology</subject><subject>IFN-γ</subject><subject>Immunoglobulins</subject><subject>Inflammatory bowel disease</subject><subject>interferon γ</subject><subject>interleukin</subject><subject>Interleukin-6 - biosynthesis</subject><subject>Interleukin-6 - immunology</subject><subject>LECs</subject><subject>Liver and Biliary Disease</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis, Biliary - immunology</subject><subject>Liver diseases</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>lung epithelial cells</subject><subject>Male</subject><subject>Measurement</subject><subject>Medical sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>PBC</subject><subject>PBS</subject><subject>phosphate buffered saline</subject><subject>Physiological aspects</subject><subject>primary biliary cirrhosis</subject><subject>primary sclerosing cholangitis</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>PSC</subject><subject>Rodents</subject><subject>SDS-PAGE</subject><subject>Smooth muscle</subject><subject>sodium dodecyl sulphate-polyacrylamide gel electrophoresis</subject><subject>Statistics, Nonparametric</subject><subject>TNF-α</subject><subject>tumour necrosis factor α</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhiMEoqVw44wsIeDCFjsfdnJBqnaBRargQEGIi-U4k6zbrL3YDm1_Fv-QCRu6LAJkKbFmnvl6PUnykNFjxjL-ohviccGO8aT0VnLIcl7OsrQsbyeHlDIxK0ReHST3QjinlJZlxe4mB4gKwWh-mHxfmm5FWg9fB7D6mriWqCE6ZaOpXWMgEGPJRkUDNgZyaeKKbLxZK39Ngu7Bu2BsR_TK9cp2JppA4kpFUhvb4Kc3IwgbDAO890RD3wei0InAoIHA1cZDCMbZsfR8kec_vRvv0B0ns7ERfA_DBfbC7yd3WtUHeDD9j5KPr1-dzZez0_dv3s5PTmc151WcgW5oXZd1U2c5TlsXaauoyhnLW9rwNK051S1jminNtEjbvGk0ytKUDeNNxuvsKJlt84ZL2Ay1nMaWThk5mS7wBrKosqISyIt_8uM4u6BfgazKMiZyjHy5jUT3GhqNUnvV7yfY81izkp37JpkQWSpKTPB0SuAdvmOIcm3CKLWy4IYgBSszkQuO4OM_wHM3eIsyjrmqKk8FH6nnW6pTPUhjW4dVdQcWsLiz0Bo0n5QVFZxWbCfUHo6ngbXRf-On9Bq3J3hobyZlVI4rLXGlZcEknpQi_uh3dXbwtMMIPJkAFbTqW6-sNmHHZSITHB_ppk8TIlzd-JW_kByRQr77NJeLZXH2efHlgxxleLbl6_X5_1v8Aa1dIXU</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Xu, B</creator><creator>Broome, U</creator><creator>Ericzon, B-G</creator><creator>Sumitran-Holgersson, S</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>Copyright 2002 by Gut</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20020701</creationdate><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><author>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>adhesion molecules</topic><topic>Adult</topic><topic>Aged</topic><topic>AIH</topic><topic>ALDs</topic><topic>Antigens</topic><topic>Autoantibodies</topic><topic>Autoantibodies - blood</topic><topic>Autoimmune diseases</topic><topic>autoimmune hepatitis</topic><topic>autoimmune liver diseases</topic><topic>BECs</topic><topic>Bile Ducts - immunology</topic><topic>biliary epithelial cells</topic><topic>Binding sites</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Cell Separation</topic><topic>Cells, Cultured</topic><topic>Chi-Square Distribution</topic><topic>Cholangitis</topic><topic>Cholangitis, Sclerosing - immunology</topic><topic>Complement Fixation Tests</topic><topic>cytokines</topic><topic>Epithelial Cells - immunology</topic><topic>Female</topic><topic>FITC</topic><topic>fluorescein isothiocynate</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatitis</topic><topic>Hepatitis, Autoimmune - immunology</topic><topic>Humans</topic><topic>Hyaluronan Receptors - immunology</topic><topic>IFN-γ</topic><topic>Immunoglobulins</topic><topic>Inflammatory bowel disease</topic><topic>interferon γ</topic><topic>interleukin</topic><topic>Interleukin-6 - biosynthesis</topic><topic>Interleukin-6 - immunology</topic><topic>LECs</topic><topic>Liver and Biliary Disease</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis, Biliary - immunology</topic><topic>Liver diseases</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>lung epithelial cells</topic><topic>Male</topic><topic>Measurement</topic><topic>Medical sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>PBC</topic><topic>PBS</topic><topic>phosphate buffered saline</topic><topic>Physiological aspects</topic><topic>primary biliary cirrhosis</topic><topic>primary sclerosing cholangitis</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>PSC</topic><topic>Rodents</topic><topic>SDS-PAGE</topic><topic>Smooth muscle</topic><topic>sodium dodecyl sulphate-polyacrylamide gel electrophoresis</topic><topic>Statistics, Nonparametric</topic><topic>TNF-α</topic><topic>tumour necrosis factor α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, B</creatorcontrib><creatorcontrib>Broome, U</creatorcontrib><creatorcontrib>Ericzon, B-G</creatorcontrib><creatorcontrib>Sumitran-Holgersson, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, B</au><au>Broome, U</au><au>Ericzon, B-G</au><au>Sumitran-Holgersson, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>51</volume><issue>1</issue><spage>120</spage><epage>127</epage><pages>120-127</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>12077104</pmid><doi>10.1136/gut.51.1.120</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-5749 |
ispartof | Gut, 2002-07, Vol.51 (1), p.120-127 |
issn | 0017-5749 1468-3288 1458-3288 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_593597 |
source | PubMed Central |
subjects | adhesion molecules Adult Aged AIH ALDs Antigens Autoantibodies Autoantibodies - blood Autoimmune diseases autoimmune hepatitis autoimmune liver diseases BECs Bile Ducts - immunology biliary epithelial cells Binding sites Biological and medical sciences Case-Control Studies Cell Separation Cells, Cultured Chi-Square Distribution Cholangitis Cholangitis, Sclerosing - immunology Complement Fixation Tests cytokines Epithelial Cells - immunology Female FITC fluorescein isothiocynate Gastroenterology. Liver. Pancreas. Abdomen Hepatitis Hepatitis, Autoimmune - immunology Humans Hyaluronan Receptors - immunology IFN-γ Immunoglobulins Inflammatory bowel disease interferon γ interleukin Interleukin-6 - biosynthesis Interleukin-6 - immunology LECs Liver and Biliary Disease Liver cirrhosis Liver Cirrhosis, Biliary - immunology Liver diseases Liver. Biliary tract. Portal circulation. Exocrine pancreas lung epithelial cells Male Measurement Medical sciences Medicin och hälsovetenskap Middle Aged Other diseases. Semiology Pathogenesis Patients PBC PBS phosphate buffered saline Physiological aspects primary biliary cirrhosis primary sclerosing cholangitis Protein Binding Proteins PSC Rodents SDS-PAGE Smooth muscle sodium dodecyl sulphate-polyacrylamide gel electrophoresis Statistics, Nonparametric TNF-α tumour necrosis factor α |
title | High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A40%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20frequency%20of%20autoantibodies%20in%20patients%20with%20primary%20sclerosing%20cholangitis%20that%20bind%20biliary%20epithelial%20cells%20and%20induce%20expression%20of%20CD44%20and%20production%20of%20interleukin%206&rft.jtitle=Gut&rft.au=Xu,%20B&rft.date=2002-07-01&rft.volume=51&rft.issue=1&rft.spage=120&rft.epage=127&rft.pages=120-127&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.51.1.120&rft_dat=%3Cgale_swepu%3EA89076091%3C/gale_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1779942766&rft_id=info:pmid/12077104&rft_galeid=A89076091&rfr_iscdi=true |